These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3504 related items for PubMed ID: 6442014

  • 1. Monoclonal antibody to human tissue plasminogen activator.
    Matsuo O, Tanbara Y, Okada K, Bando H, Nagoya T.
    Thromb Res; 1984 Dec 15; 36(6):517-26. PubMed ID: 6442014
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of epitopes on human tissue plasminogen activator recognised by a group of monoclonal antibodies.
    MacGregor IR, Micklem LR, James K, Pepper DS.
    Thromb Haemost; 1985 Feb 18; 53(1):45-50. PubMed ID: 2581330
    [Abstract] [Full Text] [Related]

  • 3. Characterization of two monoclonal antibodies against human tissue-type plasminogen activator.
    Schleef RR, Sinha M, Loskutoff DJ.
    Thromb Haemost; 1985 Apr 22; 53(2):170-5. PubMed ID: 4040658
    [Abstract] [Full Text] [Related]

  • 4. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
    Ding H, Wang JY, Song HY.
    Chin J Biotechnol; 1990 Apr 22; 6(3):223-7. PubMed ID: 2129498
    [Abstract] [Full Text] [Related]

  • 5. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
    Andreasen PA, Christensen TH, Huang JY, Nielsen LS, Wilson EL, Danø K.
    Mol Cell Endocrinol; 1986 May 22; 45(2-3):137-47. PubMed ID: 3011558
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM, Dewerchin M, Lijnen HR, Bernar H, Bulens F, Nelles L, Collen D.
    Eur J Biochem; 1992 Apr 01; 205(1):139-46. PubMed ID: 1313361
    [Abstract] [Full Text] [Related]

  • 7. Characterization of functional domains in human tissue-type plasminogen activator with the use of monoclonal antibodies.
    Holvoet P, Lijnen HR, Collen D.
    Eur J Biochem; 1986 Jul 01; 158(1):173-7. PubMed ID: 3089776
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme.
    Kaltoft K, Nielsen LS, Zeuthen J, Danø K.
    Proc Natl Acad Sci U S A; 1982 Jun 01; 79(12):3720-3. PubMed ID: 6808514
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies.
    Grøndahl-Hansen J, Nielsen LS, Kristensen P, Grøndahl-Hansen V, Andreasen PA, Danø K.
    Br J Dermatol; 1985 Sep 01; 113(3):257-63. PubMed ID: 3933538
    [Abstract] [Full Text] [Related]

  • 10. Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.
    Lijnen HR, Dewerchin M, De Cock F, Collen D.
    Thromb Res; 1990 Feb 01; 57(3):333-42. PubMed ID: 2107593
    [Abstract] [Full Text] [Related]

  • 11. [Use of monoclonal antibodies in the diagnosis of fibrinolysis].
    Wojta J, Korninger C, Kirchheimer J, Hattey E, Turcu L, Binder BR.
    Wien Klin Wochenschr; 1985 Mar 01; 97(5):244-8. PubMed ID: 4039506
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of fibrinolysis by bispecific monoclonal antibodies reactive to fibrin and plasminogen activators.
    Kurokawa T, Iwasa S, Kakinuma A.
    Thromb Res Suppl; 1990 Mar 01; 10():83-9. PubMed ID: 2107601
    [Abstract] [Full Text] [Related]

  • 13. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 01; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 14. [Functional characterization of a monoclonal antibody which interferes with the binding of t-PA to fibrin].
    Orbe J, Montes R, Chordá C, Páramo JA, Rocha E.
    Sangre (Barc); 1994 Aug 01; 39(4):261-6. PubMed ID: 7985055
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator secreted by cultured human melanocytes.
    Hashimoto K, Horikoshi T, Nishioka K, Yoshikawa K, Carter DM.
    Br J Dermatol; 1986 Aug 01; 115(2):205-9. PubMed ID: 3091061
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.
    Kurokawa T, Iwasa S, Kakinuma A, Stassen JM, Lijnen HR, Collen D.
    Thromb Haemost; 1991 Dec 02; 66(6):684-93. PubMed ID: 1796414
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum.
    Urdén G, Johansson U, Chmielewska J, Brandt J, Wiman B.
    Thromb Haemost; 1986 Jun 30; 55(3):383-7. PubMed ID: 3092395
    [Abstract] [Full Text] [Related]

  • 18. Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.
    Kirchheimer JC, Wojta J, Christ G, Binder BR.
    Proc Natl Acad Sci U S A; 1989 Jul 30; 86(14):5424-8. PubMed ID: 2501786
    [Abstract] [Full Text] [Related]

  • 19. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
    Holvoet P, Laroche Y, Lijnen HR, Van Hoef B, Brouwers E, De Cock F, Lauwereys M, Gansemans Y, Collen D.
    Eur J Biochem; 1992 Dec 15; 210(3):945-52. PubMed ID: 1483477
    [Abstract] [Full Text] [Related]

  • 20. Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin.
    Dewerchin M, Lijnen HR, Van Hoef B, De Cock F, Collen D.
    Eur J Biochem; 1989 Oct 20; 185(1):141-9. PubMed ID: 2530085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 176.